Merck Supports PAH Patients With Unbranded Campaign -- And New Drug mediapost.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from mediapost.com Daily Mail and Mail on Sunday newspapers.
The FDA approval marks a milestone for Merck, which acquired the pulmonary arterial hypertension treatment in 2021 through its $11.5 billion buyout of Acceleron Pharma.